|
(11) | EP 0 502 105 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | NON-REPLICATING RECOMBINANT-MADE RETROVIRAL PARTICLES USED AS ANTIVIRAL AGENTS AND IMMUNOGENS |